Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Regulus Therapeutics

Regulus Therapeutics reported $415K in Interest Income for its fiscal quarter ending in March of 2023.

Interest Income Change
Alnylam Pharmaceuticals ALNY:US USD 18.65M 4.58M
Biogen BIIB:US USD 80.9M 31M
Immunic Inc. VTL:US USD 800K 102K
Intrexon XON:US USD 633K 631K
Regulus Therapeutics RGLS:US USD 415K 82K
Sangamo BioSciences SGMO:US USD 3.29M 385K